Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$13.21−0.80 (-5.71%)
Close on Nov 20, 2026Market cap $956.25MP/E –Yield –
Omeros gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Omeros's gross profit for the twelve months ending Mar 31, 2021 was $70.44M, down 37.4% year over year. For fiscal 2020 it was $72.91M, down 34.3% from the year before. The highest annual figure on record is $110.94M in fiscal 2019.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $72.91M | -34.3% |
| FY2019 | Dec 31, 2019 | $110.94M | +277.9% |
| FY2018 | Dec 31, 2018 | $29.36M | -53.9% |
| FY2017 | Dec 31, 2017 | $63.75M | +58.6% |
| FY2016 | Dec 31, 2016 | $40.21M | +222.5% |
| FY2015 | Dec 31, 2015 | $12.47M | +2213.2% |
| FY2014 | Dec 31, 2014 | $539.00K | -66.3% |
| FY2013 | Dec 31, 2013 | $1.60M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $27.73M | +33.3% |
| Q1 FY2026 | Mar 31, 2026 | $9.31M | -11.7% |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $0 | -100.0% |
| Q1 FY2021 | Mar 31, 2021 | $20.80M | -10.6% |
| Q4 FY2020 | Dec 31, 2020 | $10.55M | -68.1% |
| Q3 FY2020 | Sep 30, 2020 | $25.71M | -13.1% |
| Q2 FY2020 | Jun 30, 2020 | $13.38M | -49.9% |
| Q1 FY2020 | Mar 31, 2020 | $23.27M | +7.5% |
| Q4 FY2019 | Dec 31, 2019 | $33.02M | +51.0% |
| Q3 FY2019 | Sep 30, 2019 | $29.58M | +546.9% |
| Q2 FY2019 | Jun 30, 2019 | $26.70M | +1634.8% |
| Q1 FY2019 | Mar 31, 2019 | $21.65M | +1463.0% |
| Q4 FY2018 | Dec 31, 2018 | $21.86M | +64.4% |
| Q3 FY2018 | Sep 30, 2018 | $4.57M | -78.7% |
| Q2 FY2018 | Jun 30, 2018 | $1.54M | -90.9% |
| Q1 FY2018 | Mar 31, 2018 | $1.39M | -88.4% |
| Q4 FY2017 | Dec 31, 2017 | $13.30M | +6.1% |
| Q3 FY2017 | Sep 30, 2017 | $21.47M | +96.8% |
| Q2 FY2017 | Jun 30, 2017 | $16.99M | +75.6% |
| Q1 FY2017 | Mar 31, 2017 | $11.99M | – |
| Q4 FY2016 | Dec 31, 2016 | $12.53M | – |
| Q3 FY2016 | Sep 30, 2016 | $10.91M | – |
| Q2 FY2016 | Jun 30, 2016 | $9.68M | – |
See a number that looks wrong?